In a study of patients with intracerebral hemorrhage, those with baseline creatinine levels of 110 µmol/L or higher and who received higher doses of nicardipine, a hypertensive drug, had an increased risk for acute kidney injury.
Among patients with unruptured brain arteriovenous malformation, medical management alone is superior to its combination with interventional therapy for prevention of death or symptomatic stroke in the long term.
Administration of DOAC in combination with an antiplatelet agent may reduce the risk for hemorrhagic and embolic events in patients with nonvalvular atrial fibrillation following carotid artery stenting.
Patients with chronic lower extremity artery disease treated with a more vs less intensive antithrombotic therapeutic regimen were found to be at lower risk for limb amputation, stroke, and revascularization.
Researchers explored the incidence, clinical characteristics, associated factors, and clinical outcomes of late cerebrovascular events >30- days after TAVR.
